Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV

NCT00313287 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bukwang Pharmaceutical